Not finding it? Sign in to also search OpenAlex live.
-
Synchronous diffuse large B-cell lymphoma and mantle cell lymphoma: support for low-threshold biopsies and genetic testing2021 Leukemia & lymphoma/Leukemia and lymphoma article Medicine Lymphoma Diagnosis and Treatment Open access
Fleur A. de Groot, Lorraine M. de Haan, Ruben A. L. de Groen, Linda Heijmen, Tom van Wezel, Ronald van Eijk, +8 more
3citations -
High complete response rates and minimal residual disease (MRD) negativity, with durable responses, in high-risk mantle cell lymphoma (MCL) with GLPG5101, a fresh, early memory-enriched CAR T-cell therapy with a 7-day vein-to-vein time: Results from the ATALANTA-1 MCL cohort
Marie José Kersten, Joost S.P. Vermaat, Pim G. N. J. Mutsaers, Maria Theresa Kuipers, Évelyne Willems, Sébastien Anguille, +14 more
3citations -
275 | RADIOTHERAPY IN PATIENTS WITH ADVANCED STAGE MANTLE CELL LYMPHOMA ACHIEVES DURABLE LOCAL TUMOR CONTROL—A SAKK/GLA/EMCL REAL‐WORLD‐ANALYSIS FROM THE EMCL‐REGISTRY
Sophia Drabke, Marie‐Kristin Tilch, Christiane Pott, María Gomes da Silva, Elisabeth Silkenstedt, Thomas Melchardt, +20 more
0citations -
CD19 CAR T-cell therapy (GLPG5101) for relapsed or refractory B-cell non-Hodgkin lymphoma (ATALANTA-1): phase 1 results from a single-arm, multicentre, phase 1/2 study
Marie José Kersten, Maria Theresa Kuipers, Pim G. N. J. Mutsaers, Évelyne Willems, Kirsten Saevels, Martin H. Dreyling, +14 more
0citations -
Atalanta-1: A Phase 1/2 Trial of GLPG5101, a Fresh, Stem-like, Early Memory CD19 CAR T-Cell Therapy with a 7-Day Vein-to-Vein Time, for the Treatment of Relapsed/Refractory Non-Hodgkin Lymphoma
Marie José Kersten, Kirsten Saevels, Évelyne Willems, Marte C. Liefaard, Stavros Milatos, Margot J. Pont, +9 more
3citations -
CT-945: Low Rates of High-Grade Toxicities With GLPG5101, a Fresh, Stem-Like, Early Memory Phenotype Anti-CD19 CAR T-Cell Therapy, in Patients With Non-Hodgkin Lymphoma in the ATALANTA-1 Study
Joost S.P. Vermaat, Sébastien Anguille, Maria Theresa Kuipers, Pim G. N. J. Mutsaers, Évelyne Willems, Michael R Bishop, +10 more
0citations -
465 | LOW RATES OF HIGH‐GRADE TOXICITIES WITH GLPG5101, A FRESH, STEM‐LIKE, EARLY MEMORY PHENOTYPE ANTI‐CD19 CAR T‐CELL THERAPY IN PATIENTS WITH NHL IN THE ATALANTA‐1 STUDY
Joost S.P. Vermaat, Sébastien Anguille, Maria Theresa Kuipers, Pim G. N. J. Mutsaers, E. Willems, Michael Russell Bishop, +9 more
1citations -
Safety, Tolerability, Pharmacokinetics (PK) and Preliminary Antitumor Activity of the Cyclin-Dependent Kinase-9 (CDK9) Inhibitor AZD4573 in Relapsed/Refractory Hematological Malignancies: A Phase 1 First-in-Human Study
Tim H. Brümmendorf, Patrick G. Medd, Raphael Koch, Stephan Stilgenbauer, Shringi Sharma, Yun He, +4 more
8citations